141 related articles for article (PubMed ID: 8084837)
21. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
Oesterling JE
J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
[TBL] [Abstract][Full Text] [Related]
22. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
[TBL] [Abstract][Full Text] [Related]
23. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
Douglas TH; Morgan TO; McLeod DG; Moul JW; Murphy GP; Barren R; Sesterhenn IA; Mostofi FK
Cancer; 1997 Jul; 80(1):107-14. PubMed ID: 9210715
[TBL] [Abstract][Full Text] [Related]
24. The use of real-time quantitative PCR to detect circulating prostate-specific membrane antigen mRNA in patients with prostate carcinoma.
Chu DC; Chuang CK; Liou YF; Tzou RD; Lee HC; Sun CF
Ann N Y Acad Sci; 2004 Jun; 1022():157-62. PubMed ID: 15251956
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA).
Tykvart J; Navrátil V; Sedlák F; Corey E; Colombatti M; Fracasso G; Koukolík F; Bařinka C; Sácha P; Konvalinka J
Prostate; 2014 Dec; 74(16):1674-90. PubMed ID: 25262926
[TBL] [Abstract][Full Text] [Related]
26. Prostate-specific membrane antigen: evidence for the existence of a second related human gene.
Leek J; Lench N; Maraj B; Bailey A; Carr IM; Andersen S; Cross J; Whelan P; MacLennan KA; Meredith DM
Br J Cancer; 1995 Sep; 72(3):583-8. PubMed ID: 7669565
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
[TBL] [Abstract][Full Text] [Related]
28. Development and evaluation of an enzyme-linked immunoassay for the prostate: specific antigen utilizing two monoclonal antibodies.
Zundel D; Jarry H; Kestler D; Holzapfel G; Bartels H; Scheit KH; Wuttke W
Urol Res; 1990; 18(5):327-30. PubMed ID: 1701585
[TBL] [Abstract][Full Text] [Related]
29. PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donors.
Reissigl A; Pointner J; Horninger W; Strasser H; Mayersbach P; Klocker H; Schönitzer D; Bartsch G
Prostate; 1997 Jan; 30(1):20-5. PubMed ID: 9018331
[TBL] [Abstract][Full Text] [Related]
30. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.
Heston WD
Urology; 1997 Mar; 49(3A Suppl):104-12. PubMed ID: 9123729
[TBL] [Abstract][Full Text] [Related]
31. Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients.
Murphy G; Ragde H; Kenny G; Barren R; Erickson S; Tjoa B; Boynton A; Holmes E; Gilbaugh J; Douglas T
Anticancer Res; 1995; 15(4):1473-9. PubMed ID: 7544569
[TBL] [Abstract][Full Text] [Related]
32. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
[TBL] [Abstract][Full Text] [Related]
33. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.
Su SL; Huang IP; Fair WR; Powell CT; Heston WD
Cancer Res; 1995 Apr; 55(7):1441-3. PubMed ID: 7882349
[TBL] [Abstract][Full Text] [Related]
34. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization.
Gala JL; Heusterspreute M; Loric S; Hanon F; Tombal B; Van Cangh P; De Nayer P; Philippe M
Clin Chem; 1998 Mar; 44(3):472-81. PubMed ID: 9510850
[TBL] [Abstract][Full Text] [Related]
35. Prostate antigen: a new potential marker for prostatic cancer.
Wang MC; Papsidero LD; Kuriyama M; Valenzuela LA; Murphy GP; Chu TM
Prostate; 1981; 2(1):89-96. PubMed ID: 6169079
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas.
Beckett ML; Lipford GB; Haley CL; Schellhammer PF; Wright GL
Cancer Res; 1991 Feb; 51(4):1326-33. PubMed ID: 1705172
[TBL] [Abstract][Full Text] [Related]
37. Cellular distribution and heterogeneity of Psa and Psma expression in normal, hyperplasia and human prostate cancer.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Horchani A; Oueslati R
Tunis Med; 2013 Jul; 91(7):458-63. PubMed ID: 24008878
[TBL] [Abstract][Full Text] [Related]
38. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
Stenman UH; Leinonen J; Alfthan H; Rannikko S; Tuhkanen K; Alfthan O
Cancer Res; 1991 Jan; 51(1):222-6. PubMed ID: 1703033
[TBL] [Abstract][Full Text] [Related]
39. Detection of circulating prostate tumor cells: alternative spliced variant of PSM induced false-positive result.
Hisatomi H; Nagao K; Kawakita M; Matsuda T; Hirata H; Yamamoto S; Nakamoto T; Harasawa H; Kaneko N; Hikiji K; Tsukada Y
Int J Mol Med; 2002 Nov; 10(5):619-22. PubMed ID: 12373303
[TBL] [Abstract][Full Text] [Related]
40. Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex.
Sinha AA; Wilson MJ; Gleason DF
Cancer; 1987 Sep; 60(6):1288-93. PubMed ID: 2441840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
